BioLine RX Ltd Cash Flow-to-Debt Ratio
BioLine RX Ltd cash flow-to-debt ratio. BioLine RX Ltd (BLRX) has a Cash Flow-to-Debt Ratio of -0.19x as of June 2026, meaning its operating cash flow of ILA-3.19 Million could theoretically repay 0% of its total liabilities (ILA16.75 Million) in one year. Check earnings quality score of BioLine RX Ltd to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of BioLine RX Ltd (2010–2025)
Cash flow-to-debt ratio of BioLine RX Ltd from 2010 to 2025. Historical debt coverage capacity for BioLine RX Ltd across 16 annual periods. Check BLRX cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
BioLine RX Ltd Cash Flow-to-Debt Ratio by Year (2010–2025)
BioLine RX Ltd cash flow-to-debt ratio by year from 2010 to 2025. Year-by-year debt coverage analysis for BioLine RX Ltd. For the full cash flow conversion analysis, see BioLine RX Ltd cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.50x | ILA-8.74 Million | ILA17.56 Million | ▲ +71.1% |
| 2024 | -1.72x | ILA-43.87 Million | ILA25.45 Million | ▼ -286.7% |
| 2023 | -0.45x | ILA-22.61 Million | ILA50.70 Million | ▲ +56.6% |
| 2022 | -1.03x | ILA-26.24 Million | ILA25.54 Million | ▲ +42.0% |
| 2021 | -1.77x | ILA-23.57 Million | ILA13.30 Million | ▼ -92.9% |
| 2020 | -0.92x | ILA-23.21 Million | ILA25.26 Million | ▲ +18.2% |
| 2019 | -1.12x | ILA-22.67 Million | ILA20.19 Million | ▲ +30.8% |
| 2018 | -1.62x | ILA-24.19 Million | ILA14.91 Million | ▲ +36.2% |
| 2017 | -2.54x | ILA-20.55 Million | ILA8.08 Million | ▲ +31.5% |
| 2016 | -3.71x | ILA-14.51 Million | ILA3.91 Million | ▲ +3.3% |
| 2015 | -3.84x | ILA-14.17 Million | ILA3.69 Million | ▼ -16.6% |
| 2014 | -3.29x | ILA-14.48 Million | ILA4.40 Million | ▼ -34.4% |
| 2013 | -2.45x | ILA-20.23 Million | ILA8.27 Million | ▼ -13.6% |
| 2012 | -2.15x | ILA-20.11 Million | ILA9.34 Million | ▼ -30.7% |
| 2011 | -1.65x | ILA-11.22 Million | ILA6.81 Million | ▼ -425.9% |
| 2010 | 0.51x | ILA11.46 Million | ILA22.65 Million | — |